BioGene Therapeutics Inc. — Form D

BioGene Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-23. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-07-23
• Form: D
• Accession: 0002140719-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $4.5M
• Amount sold: $4.5M
• Investors: 6
• Revenue range: Decline to Disclose
• SEC file number: 021-591997

Issuer

• Name: BioGene Therapeutics Inc.
• CIK: 0002140719
• Entity type: Corporation
• Jurisdiction: TEXAS
• Address: 5900 BALCONES DR, STE 100, AUSTIN, TX, 78731
• Phone: 1-512-379-7526

Officers, directors & promoters (6)

Other filings by this issuer (4)

More

• CIK 2140719 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search